Source file signed link, expires in 15 minutes
Extracted text 17
Page 1
Public Expose September 2025
Page 2
Company Structure
PT Ekon Prima Dra. Hetty Soetikno Masyarakat
8,99% 65,94% 25,07%
Distribution & Medical Device
75.00% 51.00%
Distributor Distributor Marketing and Sales Manufacturer Digital Platform
of pharmaceuticals, of pharmaceuticals and of medical devices of medical devices to aggregate demand on
medical devices, and health products prescription drugs at
health products for both in Cambodia marketplace
regular and JKN (BPJS) 2
market in Indonesia
Est. 1980 Est. 2018 Est. 1981 Est. 2020 Est. 2022
2
Page 3
Milestone
With over 44 years of expertise, Medela Potentia has
transformed into one of Indonesia’s premier integrated
distribution platforms, delivering a diverse range of 2023 - Present
products nationwide — including our own line of
manufactured medical devices. ▪ 2023 : expanded into
cosmetic, beauty and baby
2018 - 2022 products distribution.
▪ 2018 : was ▪ 2023: Enhanced digital
established in Cambodia, offerings through the
2011 marking MP’s first implementation of
international expansion.
▪ 2011 : was ▪ 2023: factory
established as a holding was officially inaugurated by
▪ 2022 : was
company. the Minister of Health of
2010 established as a
the Republic of Indonesia.
▪ 2011 : expanded pharmacy aggregator
into consumer product to capture growing
▪ 2010 : ▪ 2024 : officially
distribution. e-commerce demand.
was repositioned as became a publicly listed
a sales & marketing company.
arm for medical ▪ 2020 : was
devices and established as a medical
launched its own device manufacturer.
brand, Stardec.
PRIVATE & CONFIDENTIAL 3
Page 4
Driving Growth Through Network Expansion
Nationwide, Interconnected Distribution Network Supporting the Growth of Indonesia's Healthcare System
Our Infrastructure1 Our Sale’s Channels
New Branches 2024:
35 Retail Warehouses >3,500 >23,000 Pangkal Pinang and Palu
35 Sales Office (Branch) Clinics Pharmacies
3 Representative Sales Office >50,000 >2,000
2 National Distribution Center (NDC) Modern Trade Government
>700 Sales force >3,000
Institutions
Our Capacity1 Hospitals >1,300
PBF2 & PAK3
>75,000 m³ storage capacity >20,0004
>2,000 m³ cold chain capacity Others NDC
Our strong
commitment to
highest compliance
Our Penetration
Cambodia
Our infrastructure1
Directly
Hospital 97.1% Pharmacies 3 Branches
covered NDC
1 National Distribution Center (NDC)
2 Retail Warehouses
79,8% >40 Sales force
Our capacity
Total 3,2045 hospitals as of 2024. Total 30,1996 registered pharmacies as of 2021. 1,800 m³ storage capacity
Notes: 1 As of Aug 2024; 2 Pedagang Besar Farmasi (pharmaceutical wholesaler); 3 Pedagang Alat Kesehatan (medical devices wholesaler); 4 Consist of general trade, veterinaries, optics, laboratories, salon and beauty store and others; 5
Sourced from Kementrian Kesehatan 2024; 6 Sourced from Kementrian Kesehatan 2021;
PRIVATE & CONFIDENTIAL 4
Page 5
1H 2025 Summary:
Maintaining Growth with Strong Fundamental
Maintain Overall
Strong Profit Growth
Revenue Growth Additional of New
IDR 200 B
IDR 7.4 T Partners
+15.8%
+3.7%
Medical Device
Strong Growth with New Committed to ESG with
Manufacturing: High
Initiatives both in B2B Impactful Activities &
Growth with New
and B2C Platforms External Recognition
Product Launched
Page 6
Sustainable Margin Trend
Consolidated Profitability Performance
In IDR Bio, unless otherwise stated
Net Sales Gross Profit EBITDA Net Profit
8, 000
7, 000
1,000 10.0%
3.9% 3.9% 4.0% 400
6, 000
9.6%
2.7%
500 3.0%
900 3.9%
350
9.3% 9.5%
800 3.8%
2.4%
5, 000
Gr 400
300
2.5%
+3.7% 700
9.0%
3.7%
250
4, 000
2.0%
600 3.6%
7,153 7,420 300
3, 000
500
Gr 8.5% 3.5% 200
1.5%
400
+7.1% Gr 3.4%
Gr
713
150
2, 000
300
666 8.0%
200
+4.0% 3.3%
+15.8% 1.0%
281 292 100
200
200
7.5%
100
3.2% 173
1, 000
0.5%
50
100 3.1%
- 0.0%
- - 3.0%
- 7.0%
S1'24 S1'25 S1'24 S1'25 S1'24 S1'25 S1'24 S1'25
Gross Profit %GM to NS EBITDA %EBITDA to NS PAT %Net Profit to NS
Consolidated
Continued Top-line Improvement on gross Stable EBITDA margin Double digit growth on
Growth profit margin trend trend net profit, higher than
driven by principal and net sales growth
product portfolio
Source : PT Medela Potentia Tbk and its subsidiaries unaudited Jun’25 financial report
Page 7
Healthy cash balance supported by positive operating cash flow
In IDR Bio, unless otherwise stated
Operating Investing Financing
+161 bIDR -113 bIDR +497 bIDR
( 122 ) ( 20 ) ( 19 )
658
292 ( 55 ) ( 61 )
( 14 )
( 108 ) 881
(6)
335
Dec'24 EBITDA Working Capital Tax Payment Other Capital Short-term IPO Proceed Bank Loan Rent payment Others Jun'25
Expenditure-Net Investment
Realized Proceed of Public Offering Use of Proceed Remaining
Share Issuance PT Anugrah Argon PT Deca Metric Proceed of Public
IPO Proceed Net Amount Total
Cost Medica Medica Offering
658,000,000,000 22,037,378,960 635,962,621,040 278,000,000,000 35,000,000,000 313,000,000,000 322,962,621,040
Source : PT Medela Potentia Tbk and its subsidiaries unaudited Jun’25 financial report
Page 8
Distribution Project & Initiatives Update
National Distribution Center Medan New Warehouse - Supply Chain Optimization
Acquisition Finalization
• Objectives: Digitalize Planning to
Projects & Initiatives
• Executed May 2025 • Land acquired: 2023 Improve Productivity & Accuracy
• Land size: 10,000 m2 • Land size: 9,258m2 • Features: ANAPLAN with AI
• Facilities: 13,000 pallet position • Facilities: 2000 pallet position
1H 2025
Optimizer Planning System
• Ambient Room <30°C • (2°-8°C, <25°C, <30°C) • Result: Forecast Accuracy & Out of
• Cool Room <25°C • Start build: Aug 2025 Stock improvement
• Cold Storage 2°-8°C • Estimated ready: Q4 2026
Forecast Accuracy Out of Stock
100% 3%
1H 2024 1H 2025 1H 2024 1H 2025
2H Focus
1. Medan Warehouse ground breaking and start building 3. Cold Chain Capacity Expansion
2. Exploration of Additional National Central Warehouse: 4. New Principals
Cikarang
Page 9
Distribution Project & Initiatives Update
National Distribution Medan New Warehouse - Supply Chain Optimization New Principals
Center Acquisition Finalization
• Objectives: Digitalize Planning to
Projects & Initiatives
• Land acquired: 2023 Improve Productivity & Accuracy
• Executed May 2025 New Principals
• Features: ANAPLAN with AI
• Land size: 10,000 m2 • Land size: 9,258m2 3 joined in 1H
1H 2025
• Facilities: 2000 pallet Optimizer Planning System
• Facilities: 13,000 pallet
• (2°-8°C, <25°C, <30°C) • Result: Forecast Accuracy & Out
• Ambient Room <30°C
• Start build: Aug 2025 of Stock improvement
• Cool Room <25°C
• Cold Storage 2°-8°C • Estimated ready: Q4 2026 Out of Stock
Forecast Accuracy 1 2
100% 3%
Consumer Medical
Health Device
1H 2024 1H 2025 1H 2024 1H 2025
2H Focus
1. Medan Warehouse ground breaking and start building 3. Cold Chain Capacity Expansion
2. Exploration of Additional National Central Warehouse: 4. New Principals
Cikarang
PRIVATE & CONFIDENTIAL
Page 10
Expand Margin through Diversification into Medical Devices
Business Model Manufacturing Facility
Own
Product
Agency
• Inauguration: December
21st, 2023
Distribution • Location: Jababeka II
• Land area: 5,985 sqm • Storage area: 1,295 sqm (~1500 pallet)
• Building area: 4,800 sqm • ISO 13485 : Wound care and surgical
• Production area: 3,600 sqm supplies
✔Strengthen own product business
• Provide end to end solution for customer and ✔Government implemented a national health transformation to increase
business partners resilience in the medical device sector by supporting domestic manufacturing.
• Leveraging our relationship with channel and ✔Priority listing in the e-Katalog is given for products with a min. domestic
healthcare professional
content of 40%, based on TKDN and BMP, fully implemented starting April 2022.
PRIVATE & CONFIDENTIAL 10
Page 11
Medical Device Manufacturing Update
Product Portfolio – New Product Launch Growing Sales and Hospital Coverage
6 Brands, 13 SKU Launched 1H 2025 Coverage
+49% TOP HOSPITALS
• RS Siloam
Sales • RS Hermina
+39%
• RS Cipto M.
• RS Fatmawati
DECACARE DECAMED IV • RS Harapan Kita
Increasing Production Output 2H 2025 Focus
Total
Output Production Output: • New Product Launch: Advanced
+145% • Own Brand (Deca) Wound Care (Chronic)
• 3rd Party OEM (start • New Hospital Coverage
2H 2024) • Export Market: Cambodia
1H 24 1H 25
Page 12
Digital Main Thrust: Staying Relevant & Sustain Growth
Innovation to improve growth, productivity and asset optimization
Distributor
Principals Consumer
Digital collaboration Digital customer experience;
Growth insights Health Provider Self-service Order & Payment
Self-service Information & Complaint handling
Working Capital Optimization Productivity & Cost Efficiency Growth Enabler for Principals
• Improved demand forecasting and optimized • FF and Telesales (CSO) digitalization • Goapotik platform for Direct To Consumer
supply & allocation planning (DTC) channel
• GPOS B2B as mainstream digital CX touch point
• Improved receivables cycle through for customers • GPOS for selling-in and in-store marketing
customer-process-driven collection system and sales activation
• Optimize warehouse productivity & transport cost
management • Market-flexible OMS & campaign/discount
management
Technology deployment driving better shareholder values
PRIVATE & CONFIDENTIAL 12
Page 13
Digital B2B Update: Strong Revenue and Coverage Growth,
with Addition of New Features
● Single marketplace for healthcare providers supply needs
Toserba ● Provide digital to-market solutions for principals (pharma/non pharma)
Principals ● Extensive medical channel distribution networks
● Provide value-added services to brand/Principal: market insight, Customer reach-out,
Value Publication etc.
Proposition ● Provide in-store sales activation for brands
Principals AAM
1H 2025 Result
Coverage
300.000 +26% 14.000
12.000
250.000 10.000
8.000
200.000
Sales 6.000
150.000 +15% 4.000
2.000
100.000 0
Others Hospital Clinics Apotek 1H-24 1H-25
SALES COVERAGE
Active: >900 Active: >700 Active: >800 Active: >9000
Value Added Service: Collaborate with 14 Principals and 40 Brands
Page 14
Digital B2C Update: Strong Revenue Growth through
Partner Expansion
Enabling direct to consumer model in regulated market
Demand Creations
Brand/Principal
Partner Marketplaces Tokopedia, Blibli, Lazada, GrabMart
Collaboration
End Consumer
7500+ Apotek
45+
Health & Insurance Good Doctor
Dexa Consumer Health, Bayer, Hyphens
Brand Official Store Pharma, Djembatan Dua, Ferron, Alcon
Bespoke DTC journeys Cek Segitiga (Health Screening)
Apotek Growth in Digital
Digital Channel Visibility
Revenue # Customer # Transaction
1H 2025 +40% +30% +19%
Result
1H 2024 1H 2025 1H 2024 1H 2025 1H 2024 1H 2025
Page 15
Delivering a Better Healthcare:
Commitment to ESG
1H 2025 Update
External Recognition
Environmental Social Governance
EV Implementation
Reinforcing ethical standards
• 7.324 people impacted. and professionalism by
• 144 community-focused disseminating the Code of
activities. Ethics to all employees.
• 14 cities. 8 provinces. 3
islands. July 2nd, 2025
IDX Channel Anugerah ESG Award
Community Waste Management 2025 in the main category for the
Waste Facility Donation & healthcare sector.
Clean-Up Environment Event
The award was received by the
Human Resources & Sustainability
Director during a ceremony at the
Main Hall of the Indonesia Stock
Exchange on Friday, July 4, 2025.
Page 16
Company Strategy – Plan for 2026
1 Continue Driving Market Growth
• New Principal Exploration: Existing & New Segments
• Strengthen coverage: OOP & BPJS Market, including new channel exploration
• Exploring prudently for presence in some countries within ASEAN
• Continue exporting “Stardec” own product to countries within ASEAN Region
2 Strengthening and Modernizing Distribution System
• Capacity Expansion: Cold Chain & Non Cold Chain
• AI implementation in Business Process: Growth Exploration, Improve Productivity & Accuracy
• Exploration of Automatic System in Warehouse Infrastructure
3 Expanding Medical Device Portfolio
• Strengthen Own Product “Stardec” Portfolio: New Products Launch
• Expanding “Agency” Product Portfolio: Orthopedics & Phlebology, Minimally Invasive Surgery, and Anatomic
Pathology
4 Commitment to ESG
• Climate and Energy: Lower Emission & Renewable Energy
• Continue the Community Engagement & Contribution thru Argon Peduli
PRIVATE & CONFIDENTIAL 16
Page 17
Medela Potentia:
A Sustainable
Healthcare Business
Thank You
www.medela-potentia.com
investor.relations@medela-potentia.com
PRIVATE & CONFIDENTIAL
Names mentioned 7 people and organisations named in the text · linked when the evidence is strong
unresolved
org
Minister of Health
p.3
unresolved
org
PT Anugrah Argon
p.7
unresolved
org
PT Deca Metric
p.7
unresolved
org
Indonesia Stock Exchange
p.15
Extraction attempts how the parser did, and what it refused
Nothing structured was extracted from this document — the attempts below say why.
No extraction attempted yet.